Targeting Novel Molecular Mechanisms May Repair Damaged DNA - News CenterEZH2 protein dysregulates PARP1 activity, leading to impaired DNA repair in prostate cancer, informing potential targeted therapies for resistant cases.
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells - NatureCollaboration across institutions leads to significant advancements in cancer treatment and research.
Scientists Discover Potential Biomarker in Rare Skin Cancer - News CenterIncreased immune cell activity in Merkel cell carcinoma tumors could predict treatment response and aid in developing targeted therapies.